Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07223684 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TDAP in Burn Patients (Group 2)

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Feb 15, 2026 to May 15, 2026v3
  2. Study Status, Eligibilityv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is following adult patients with serious burn injuries to better understand how their bodies respond to treatment and recovery. Researchers will collect small amounts of blood and tissue samples, along with information already recorded in the medical record, such as vital signs, lab results, and details of surgeries or complications. The goal is to identify patterns that may help predict who is at higher risk for infections or other problems after a burn injury. This information could lead to new tools, including computer-based models, to improve burn care and outcomes in the future. Participation involves providing samples and allowing researchers to review medical records during the hospital stay and up to one year after discharge.
Trial Details
NCT Number NCT07223684
Lead Sponsor Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators: United States Department of Defense, Emory University, United States Army Institute of Surgical Research, University of South Florida, Uniformed Services University of the Health Sciences
Conditions
(from sponsor)		 Sepsis, Burn Injury, Wound Healing, Critical Illness, Multiple Organ Dysfunction Syndrome
Related terms Burns, Critical Illness, Infections, Multiple Organ Failure, Respiratory Distress Syndrome, Sepsis
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov